1. How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinoma. Issue 3 (4th March 2017) Authors: Bracarda, Sergio; Negrier, Sylvie; Casper, Jochen; Porta, Camillo; Schmidinger, Manuela; Larkin, James; Gross Goupil, Marine; Escudier, Bernard Journal: Expert review of anticancer therapy Issue: Volume 17:Issue 3(2017) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma. (February 2020) Authors: Donskov, Frede; Motzer, Robert J.; Voog, Eric; Hovey, Elizabeth; Grüllich, Carsten; Nott, Louise M.; Cuff, Katharine; Gil, Thierry; Jensen, Niels Viggo; Chevreau, Christine; Negrier, Sylvie; Depenbusch, Reinhard; Bergmann, Lothar; Cornelio, Izzy; Champsaur, Anne; Escudier, Bernard; Pal, Sumanta; ... Journal: European journal of cancer Issue: Volume 126(2020) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial. (April 2020) Authors: Negrier, Sylvie; Rioux-Leclercq, Nathalie; Ferlay, Céline; Gross-Goupil, Marine; Gravis, Gwenaëlle; Geoffrois, Lionel; Chevreau, Christine; Boyle, Helen; Rolland, Frederic; Blanc, Ellen; Ravaud, Alain; Dermeche, Slimane; Flechon, Aude; Albiges, Laurence; Pérol, David; Escudier, Bernard Journal: European journal of cancer Issue: Volume 129(2020) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients. (September 2022) Authors: Saint-Ghislain, Mathilde; Derrien, Anne-Céline; Geoffrois, Lionnel; Gastaud, Lauris; Lesimple, Thierry; Negrier, Sylvie; Penel, Nicolas; Kurtz, Jean-Emmanuel; Le Corre, Yannick; Dutriaux, Caroline; Gardrat, Sophie; Barnhill, Raymond; Matet, Alexandre; Cassoux, Nathalie; Houy, Alexandre; Ramtohul,... Journal: European journal of cancer Issue: Volume 173(2022) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study. (September 2020) Authors: de Vries-Brilland, Manon; Gross-Goupil, Marine; Seegers, Valérie; Boughalem, Elouen; Beuselinck, Benoit; Thibault, Constance; Chevreau, Christine; Ladoire, Sylvain; Barthélémy, Philippe; Negrier, Sylvie; Borchiellini, Delphine; Huillard, Olivier; Geoffrois, Lionnel; Gravis, Gwenaelle; Saldana, Ca... Journal: European journal of cancer Issue: Volume 136(2020) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis. (December 2016) Authors: Escudier, Bernard; Molinie, Vincent; Bracarda, Sergio; Maroto, Pablo; Szczylik, Cezary; Nathan, Paul; Negrier, Sylvie; Weiss, Claudia; Porta, Camillo; Grünwald, Viktor; Albiges, Laurence Journal: European journal of cancer Issue: Volume 69(2016) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study. (March 2023) Authors: Velev, Maud; Dalban, Cécile; Chevreau, Christine; Gravis, Gwenaelle; Negrier, Sylvie; Laguerre, Brigitte; Gross-Goupil, Marine; Ladoire, Sylvain; Borchiellini, Delphine; Geoffrois, Lionnel; Joly, Florence; Priou, Frank; Barthelemy, Philippe; Laramas, Mathieu; Narciso, Berangère; Thiery-Vuillemin,... Journal: European journal of cancer Issue: Volume 182(2023) Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma. (1st January 2020) Authors: Montemagno, Christopher; Hagege, Anais; Borchiellini, Delphine; Thamphya, Brice; Rastoin, Olivia; Ambrosetti, Damien; Iovanna, Juan; Rioux-Leclercq, Nathalie; Porta, Camillio; Negrier, Sylvie; Ferrero, Jean-Marc; Chamorey, Emmanuel; Pagès, Gilles; Dufies, Maeva Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗